CASEY BOWEN: Open Payments
NPI 1619144003 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$41,370 in 128 payments from 16 companies in 2025. Trend: 2023 $1,641 · 2024 $1,371 · 2025 $41,370
Speaker / faculty: $39,000Food & beverage: $1,816Travel & lodging: $469Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 54 | $40,038 |
| Lilly USA, LLC | 17 | $266 |
| Novartis Pharmaceuticals Corporation | 16 | $252 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $157 |
| GENZYME CORPORATION | 10 | $136 |
| Amgen Inc. | 3 | $71 |
| Janssen Biotech, Inc. | 4 | $69 |
| E.R. Squibb & Sons, L.L.C. | 1 | $69 |
| Regeneron Healthcare Solutions, Inc. | 2 | $68 |
| UCB, Inc. | 3 | $59 |
Products named: SKYRIZI, TALTZ, COSENTYX, DUPIXENT, RINVOQ, OTEZLA, TREMFYA, Sotyktu.
Industry payments across NE — which companies pay providers there.
